Skip to main content

Table 2 Efficacy outcomes (per protocol analysis) on days 14 and 28

From: Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up

Day 14

AM-L

AS+AQ

ACPR

100

107

ETF

0

0

LCF

1

0

LPF

2

2

Day 28

  

ACPR

97

102

ETF

0

0

LCF

3

1

LPF

3

4

  1. AM-L = artemether-lumefantrine, AS+AQ = artesunate+amodiaquine
  2. Day 28 cure rates are cumulative figures from day 14. ACPR = adequate clinical and parasitological response, ETF = early treatment failure, LCF = late clinical failure, LPF = late parasitological failure
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us